Poria cocos polysaccharide—functionalized graphene oxide nanosheet induces efficient cancer immunotherapy in mice

Introduction: Tumor vaccines that induce robust humoral and cellular immune responses have attracted tremendous interest for cancer immunotherapy. Despite the tremendous potential of tumor vaccines as an effective approach for cancer treatment and prevention, a major challenge in achieving sustained antitumor immunity is inefficient antigen delivery to secondary lymphoid organs, even with adjuvant aid. Methods: Herein, we present antigen/adjuvant integrated nanocomplexes termed nsGO/PCP/OVA by employing graphene oxide nanosheet (nsGO) as antigen nanocarriers loaded with model antigen ovalbumin (OVA) and adjuvant, Poria cocos polysaccharides (PCP). We evaluated the efficacy of nsGO/PCP/OVA in activating antigen-specific humoral as well as cellular immune responses and consequent tumor prevention and rejection in vivo. Results: The optimally formed nsGO/PCP/OVA was approximately 120–150 nm in diameter with a uniform size distribution. Nanoparticles can be effectively engulfed by dendritic cells (DCs) through receptor-mediated endocytosis, induced the maturation of DCs and improved the delivery efficiency both in vitro and in vivo. The nsGO/PCP/OVA nanoparticles also induced a significant enhancement of OVA antigen-specific Th1 and Th2 immune responses in vivo. In addition, vaccination with nsGO/PCP/OVA not only significantly suppressed tumor growth in prophylactic treatments, but also achieved a therapeutic effect in inhibiting the growth of already-established tumors. Conclusion: Therefore, this potent nanovaccine platform with nanocarrier nsGO and PCP as adjuvants provides a promising strategy for boosting anti-tumor immunity for cancer immunotherapy.

[1]  J. Sun,et al.  Lymph node-targeting nanovaccines for cancer immunotherapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[2]  J. Duan,et al.  Quantitative analysis of nutrients for nucleosides, nucleobases and amino acids hidden behind five distinct regions-derived Poria cocos using ultra-performance liquid chromatography coupled with triple-quadrupole linear ion-trap tandem mass spectrometry. , 2022, Journal of separation science.

[3]  Pan Li,et al.  Effect of steam explosion pretreatment on polysaccharide isolated from Poria cocos: Structure and immunostimulatory activity. , 2022, Journal of food biochemistry.

[4]  Bin Liu,et al.  Current Advancements in Antitumor Properties and Mechanisms of Medicinal Components in Edible Mushrooms , 2022, Nutrients.

[5]  Jike Lu,et al.  Extraction, characterization and biological activities of a polysaccharide from Poria cocos peels , 2022, Journal of Food Processing and Preservation.

[6]  N. He,et al.  A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy , 2022, Chinese Chemical Letters.

[7]  Boye Li,et al.  Poria cocos polysaccharide induced Th1-type immune responses to ovalbumin in mice , 2021, PloS one.

[8]  Jun Zhang,et al.  Polysaccharide PCP-I isolated from Poria cocos enhances the immunogenicity and protection of an anthrax protective antigen-based vaccine , 2019, Human vaccines & immunotherapeutics.

[9]  R. Janssen,et al.  Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70 years. , 2019, Vaccine.

[10]  Hualei Wang,et al.  Adjuvant activity of PCP-II, a polysaccharide from Poria cocos, on a whole killed rabies vaccine. , 2019, Virus research.

[11]  Haofei Shi,et al.  Nanotoxicity of different sizes of graphene (G) and graphene oxide (GO) in vitro and in vivo. , 2019, Environmental pollution.

[12]  Xiaoling Liu,et al.  Astragalus polysaccharides, chitosan and poly(I:C) obviously enhance inactivated Edwardsiella ictaluri vaccine potency in yellow catfish Pelteobagrus fulvidraco , 2019, Fish & shellfish immunology.

[13]  A. Farooqi,et al.  Nanoparticle systems for cancer vaccine. , 2019, Nanomedicine.

[14]  Jingwei Shao,et al.  Comparisons between Graphene Oxide and Graphdiyne Oxide in Physicochemistry Biology and Cytotoxicity. , 2018, ACS applied materials & interfaces.

[15]  A. Pandey,et al.  Graphene oxide-chloroquine nanoconjugate induce necroptotic death in A549 cancer cells through autophagy modulation. , 2018, Nanomedicine.

[16]  Noele P. Nelson,et al.  Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant , 2018, MMWR. Morbidity and mortality weekly report.

[17]  Hyun-Joon Shin,et al.  Structural, electronic structure and antibacterial properties of graphene-oxide nano-sheets , 2018 .

[18]  M. Bayati,et al.  Effects of Graphene Oxide Nanoparticles on the Immune System Biomarkers Produced by RAW 264.7 and Human Whole Blood Cell Cultures , 2018, Nanomaterials.

[19]  Bali Pulendran,et al.  AS03- and MF59-Adjuvanted Influenza Vaccines in Children , 2017, Front. Immunol..

[20]  G. Wong,et al.  Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in mice , 2017, Virology Journal.

[21]  Zhuang Liu,et al.  Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses , 2017, Nature Communications.

[22]  Myunggi An,et al.  Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy. , 2017, Bioconjugate chemistry.

[23]  A. Didierlaurent,et al.  Adjuvant system AS01: helping to overcome the challenges of modern vaccines , 2017, Expert review of vaccines.

[24]  Ligeng Xu,et al.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy , 2016, Nature Communications.

[25]  C. Zhao,et al.  Effect of a polysaccharide from Poria cocos on humoral response in mice immunized by H1N1 influenza and HBsAg vaccines. , 2016, International journal of biological macromolecules.

[26]  Feifan Zhou,et al.  A graphene oxide based smart drug delivery system for tumor mitochondria-targeting photodynamic therapy. , 2016, Nanoscale.

[27]  D. Szukiewicz,et al.  The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions , 2016, Archivum Immunologiae et Therapiae Experimentalis.

[28]  I. Melero,et al.  Evolving synergistic combinations of targeted immunotherapies to combat cancer , 2015, Nature Reviews Cancer.

[29]  Xiaoyang Xu,et al.  Cancer Nanomedicine: From Targeted Delivery to Combination Therapy , 2015, Trends in molecular medicine.

[30]  H. Kohrt,et al.  Current clinical trials testing combinations of immunotherapy and radiation. , 2015, Seminars in radiation oncology.

[31]  Yuehe Lin,et al.  In situ simultaneous monitoring of ATP and GTP using a graphene oxide nanosheet–based sensing platform in living cells , 2014, Nature Protocols.

[32]  O. Joffre,et al.  Cross-presentation by dendritic cells , 2012, Nature Reviews Immunology.

[33]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[34]  Agnes B Kane,et al.  Biological interactions of graphene-family nanomaterials: an interdisciplinary review. , 2012, Chemical research in toxicology.

[35]  Jan E Schnitzer,et al.  Overcoming in vivo barriers to targeted nanodelivery. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[36]  Deepthy Menon,et al.  Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. , 2011, Nanoscale.

[37]  Yuan Ping,et al.  Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. , 2011, Small.

[38]  Yanli Chang,et al.  In vitro toxicity evaluation of graphene oxide on A549 cells. , 2011, Toxicology letters.

[39]  Jiali Zhang,et al.  Biocompatibility of Graphene Oxide , 2010, Nanoscale research letters.

[40]  Martin F. Bachmann,et al.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.

[41]  Kai Yang,et al.  Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. , 2010, Nano letters.

[42]  Yang Xu,et al.  Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. , 2010, ACS nano.

[43]  Ke RuiDian,et al.  Analysis of chemical composition of polysaccharides from Poria cocos Wolf and its anti-tumor activity by NMR spectroscopy. , 2010 .

[44]  Lina Zhang,et al.  Chain conformation and anti-tumor activities of phosphorylated (1→3)-β-d-glucan from Poria cocos , 2009 .

[45]  J. Tascón,et al.  Graphene oxide dispersions in organic solvents. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[46]  C. Rooney,et al.  Using Dendritic Cell Maturation and IL-12 Producing Capacity as Markers of Function: A Cautionary Tale , 2008, Journal of immunotherapy.

[47]  Sven Burgdorf,et al.  Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation , 2007, Science.

[48]  S. Gordon,et al.  Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response , 2006, European journal of immunology.

[49]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[50]  Michael S. Kuhns,et al.  CTLA-4: new insights into its biological function and use in tumor immunotherapy , 2002, Nature Immunology.

[51]  M Hoffman,et al.  Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. , 1993, Journal of immunology.

[52]  Peter Walden,et al.  Exact prediction of a natural T cell epitope , 1991, European journal of immunology.